Krishna Institute of Medical Sciences (KIMS) Q1 25/26 earnings summary

Executive summary

• Revenue grew 26.8% year-over-year to INR 879 crore (₹8,716 million), with 9.6% sequential growth.

• EBITDA reached INR 200 crore, up 8.5% YoY but down 1.4% QoQ; margin at 22.7%.

• PAT for Q1 FY26 was INR 85 crore (₹786 million), down from INR 95 crore YoY and INR 106 crore QoQ.

• EPS for Q1 FY26 was INR 1.96, a 9.2% YoY decline.

• Expansion continued with new units in Thane, Bangalore, Kerala, and Andhra Pradesh.

Financial highlights

• Consolidated revenue from operations was INR 872 crore (₹8,716 million), up 26.6% YoY and 9.4% QoQ.

• EBITDA margin compressed to 22.7% from 26.6% YoY and 25.3% QoQ.

• PAT margin at 9.7%, down from 13.2% QoQ and 13.7% YoY.

• ARPOB increased 11.8% YoY and 3.7% QoQ; ARPP up 9.8% YoY and 2.7% QoQ.

• Net debt as of June 30, 2024, was INR 2,020 crore.

Outlook and guidance

• EBITDA margin guidance for FY26 is in the 22%-25% range.

• Losses from new units expected to neutralize within 12 months of full operations, especially in Bangalore and Kerala.

• Company-level ARPOB expected to rise to INR 50,000-55,000 as new units ramp up.

• Expansion plans include new hospitals and departments in Bangalore, Ongole, Anantapur, Kondapur, and Rajahmundry, with phased openings from Q2 FY26 to Q4 FY27.